Artwork

Content provided by Myriad Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Myriad Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

New Technologies Lead to Better Patient Outcomes

20:50
 
Share
 

Manage episode 288623529 series 2902383
Content provided by Myriad Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Myriad Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode Dr. Cohen sits down with Dr. Jonathan Henderson, CEO of Regional Urology in Shreveport Louisiana to discuss how the Prolaris test changed his treatment decision of multiple patients considering treatment or active surveillance. Dr. Henderson also talks about his reasoning for the early adoption of hereditary cancer screening and shares a compelling story about how genetic testing for BRCA status allowed him to get a compassionate writ for the PARP inhibitor - Lymparza which dramatically changed his patient's quality of life.

  continue reading

50 episodes

Artwork
iconShare
 
Manage episode 288623529 series 2902383
Content provided by Myriad Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Myriad Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode Dr. Cohen sits down with Dr. Jonathan Henderson, CEO of Regional Urology in Shreveport Louisiana to discuss how the Prolaris test changed his treatment decision of multiple patients considering treatment or active surveillance. Dr. Henderson also talks about his reasoning for the early adoption of hereditary cancer screening and shares a compelling story about how genetic testing for BRCA status allowed him to get a compassionate writ for the PARP inhibitor - Lymparza which dramatically changed his patient's quality of life.

  continue reading

50 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide